196 related articles for article (PubMed ID: 22052058)
1. Clusterin attenuates the development of renal fibrosis.
Jung GS; Kim MK; Jung YA; Kim HS; Park IS; Min BH; Lee KU; Kim JG; Park KG; Lee IK
J Am Soc Nephrol; 2012 Jan; 23(1):73-85. PubMed ID: 22052058
[TBL] [Abstract][Full Text] [Related]
2. The orphan nuclear receptor SHP attenuates renal fibrosis.
Jung GS; Kim MK; Choe MS; Lee KM; Kim HS; Park YJ; Choi HS; Lee KU; Park KG; Lee IK
J Am Soc Nephrol; 2009 Oct; 20(10):2162-70. PubMed ID: 19643931
[TBL] [Abstract][Full Text] [Related]
3. Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis.
Jung GS; Jeon JH; Jung YA; Choi YK; Kim HS; Kim JG; Park KG; Kim MK; Lee IK
PLoS One; 2014; 9(8):e105635. PubMed ID: 25148511
[TBL] [Abstract][Full Text] [Related]
4. Lin28a attenuates TGF-β-induced renal fibrosis.
Jung GS; Hwang YJ; Choi JH; Lee KM
BMB Rep; 2020 Nov; 53(11):594-599. PubMed ID: 33050985
[TBL] [Abstract][Full Text] [Related]
5. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK
PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222
[TBL] [Abstract][Full Text] [Related]
6. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
[TBL] [Abstract][Full Text] [Related]
7. Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.
Beghdadi W; Madjene LC; Claver J; Pejler G; Beaudoin L; Lehuen A; Daugas E; Blank U
Kidney Int; 2013 Aug; 84(2):317-26. PubMed ID: 23515052
[TBL] [Abstract][Full Text] [Related]
8. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways.
Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H
FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction.
Yao L; Wright MF; Farmer BC; Peterson LS; Khan AM; Zhong J; Gewin L; Hao CM; Yang HC; Fogo AB
Nephrol Dial Transplant; 2019 Dec; 34(12):2042-2050. PubMed ID: 31071225
[TBL] [Abstract][Full Text] [Related]
10. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
[TBL] [Abstract][Full Text] [Related]
11. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling.
You YK; Luo Q; Wu WF; Zhang JJ; Zhu HJ; Lao L; Lan HY; Chen HY; Cheng YX
J Cell Mol Med; 2019 Aug; 23(8):5576-5587. PubMed ID: 31211499
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.
Muñoz-Félix JM; López-Novoa JM; Martínez-Salgado C
Kidney Int; 2014 Feb; 85(2):319-32. PubMed ID: 23945497
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction.
Wang L; Lee JY; Kwak JH; He Y; Kim SI; Choi ME
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F508-17. PubMed ID: 18094035
[TBL] [Abstract][Full Text] [Related]
14. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin protects against renal interstitial fibrosis by suppressing TWEAK-mediated Smad3 phosphorylation.
Zeng D; Xiao Z; Xu Q; Luo H; Wen L; Tang C; Shan Y; Tian J; Wei J; Li Y
Life Sci; 2020 Nov; 260():118488. PubMed ID: 32979359
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
17. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
[TBL] [Abstract][Full Text] [Related]
18. Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction.
Liu C; Mei W; Tang J; Yuan Q; Huang L; Lu M; Wu L; Peng Z; Meng J; Yang H; Shen H; Lv B; Hu G; Tao L
PLoS One; 2015; 10(6):e0129283. PubMed ID: 26042668
[TBL] [Abstract][Full Text] [Related]
19. Elsholtzia ciliata (Thunb.) Hylander attenuates renal inflammation and interstitial fibrosis via regulation of TGF-ß and Smad3 expression on unilateral ureteral obstruction rat model.
Kim TW; Kim YJ; Seo CS; Kim HT; Park SR; Lee MY; Jung JY
Phytomedicine; 2016 Apr; 23(4):331-9. PubMed ID: 27002403
[TBL] [Abstract][Full Text] [Related]
20. Renalase Protects against Renal Fibrosis by Inhibiting the Activation of the ERK Signaling Pathways.
Wu Y; Wang L; Deng D; Zhang Q; Liu W
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
